The lawsuit is believed to be the first to reach a courtroom over the issue of heart valve damage caused by fen-phen or Redux, and experts said a victory for the woman could prove key to other cases.
American Home, through its Wyeth-Ayerst Laboratories subsidiary, marketed fenfluramine -- half of the fen-phen combination -- and Redux, a similar product.
The drug maker, in a filing with the U.S. Securities and Exchange Commission, stated it was aware of 2,615 lawsuits over fen-phen as of March 22.
The Burks settlement comes less than a month after American Home Products agreed to pay between $6 million and $7 million to settle a Harris County lawsuit linking a woman's death to fen-phen.
In the only verdict yet to be rendered in any fen-phen lawsuit, Debbie Lovett, 36, of Grand Saline, Texas was awarded $23.3 million in July by a jury for heart damage she suffered after taking fen-phen for more than three months.
Pondimin, American Home Products' brand name for fenfluramine _ the "fen" in fen-phen _ and Redux, a similar drug, were removed from the market in September 1997, 6,500 lawsuits covering 11,000 people have been filed.
In the complaint, Interneuron accuses American Home of deliberately concealing information regarding possible health risks associated with the use of "fen-phen," a combination of the anti-obesity drugs Pondimin and phentermine.
In October, Madison, N.J.-based American Home Products announced it would pay $4.8 billion to settle fen-phen lawsuits.
More than 9,000 lawsuits have been filed against American
